Search - tctmd.com

Displaying 221 - 240 of 2765

Sort: Relevancy | Date

News Opinion CV Team Dispatch

October 2024 Dispatch for the CV Team

L.A. McKeown

October 25, 2024

News Daily News

SOUL: Oral Semaglutide Cuts CV Events in Diabetic Patients

L.A. McKeown

October 23, 2024

News Daily News

Practical Strategies to Foster Diversity in Cardiology Clinical Trials

Caitlin E. Cox

October 22, 2024

News Opinion Editor's Corner TCT 2024

What’s Going to Be Big at TCT 2024?

Michael O'Riordan

October 17, 2024

News Daily News

Age Cutoffs for PFO Closure Deserve a Rethink, Researchers Urge

L.A. McKeown

October 15, 2024

News Daily News

Lp(a) Levels, Still Mostly Genetic, Sometimes Vary Over a Lifetime

Michael O'Riordan

October 14, 2024

News Daily News

AHA Statement Outlines Cardiac Contributions to Brain Health

L.A. McKeown

October 11, 2024

News Conference News EACTS 2024

MACE in CV Trials: Has the Outcome Outlived Its Role?

Yael L. Maxwell

October 11, 2024

News Daily News

Small Fraction of STEMI Patients With Shock Meet DanGer Criteria

Caitlin E. Cox

October 11, 2024

News Daily News

Low CV Risk With ‘Living’ Cancer Therapies, Meta-analysis Shows

L.A. McKeown

October 09, 2024

News Conference News HFSA 2024

Biomarker and Echo Data Bolster Vutrisiran’s Promise in ATTR-CM

L.A. McKeown

October 04, 2024

News Conference News HFSA 2024

FINEARTS-HF: New Analyses Ask, Who Benefits Most From Finerenone?

Michael O'Riordan

October 02, 2024

News Daily News

CVD Risk Twofold Higher in Patients With Cancer: ASPREE

Michael O'Riordan

September 27, 2024

News Daily News

Lingering Gaps in CVD Care for Women Spotlighted in British Consensus Statement

Todd Neale

September 26, 2024

News Daily News

Medicaid Coverage Improves CV Risk in Some, Post Hoc Analysis Shows

Todd Neale

September 25, 2024

News Daily News

Debating a PCI-First Strategy in Stable CAD: ORBITA-2 vs the Unconvinced

Michael O'Riordan

September 20, 2024

News Daily News

MI Care Varies Across Asian Subgroups in the US

Yael L. Maxwell

September 19, 2024

News Daily News

Little Pre- and Postmarket Testing for Most Recalled CV Devices

Michael O'Riordan

September 16, 2024

News Daily News

Tricuspid TEER Continues to Offer Benefits Through 3 Years: TRILUMINATE

Caitlin E. Cox

September 12, 2024

News Daily News

Statins Are Cost-effective in the Elderly

Michael O'Riordan

September 11, 2024

Advertisement

October 2024 Dispatch for the CV Team

SOUL: Oral Semaglutide Cuts CV Events in Diabetic Patients

Practical Strategies to Foster Diversity in Cardiology Clinical Trials

What’s Going to Be Big at TCT 2024?

Age Cutoffs for PFO Closure Deserve a Rethink, Researchers Urge

Lp(a) Levels, Still Mostly Genetic, Sometimes Vary Over a Lifetime

AHA Statement Outlines Cardiac Contributions to Brain Health

MACE in CV Trials: Has the Outcome Outlived Its Role?

Small Fraction of STEMI Patients With Shock Meet DanGer Criteria

Low CV Risk With ‘Living’ Cancer Therapies, Meta-analysis Shows

Biomarker and Echo Data Bolster Vutrisiran’s Promise in ATTR-CM

FINEARTS-HF: New Analyses Ask, Who Benefits Most From Finerenone?

CVD Risk Twofold Higher in Patients With Cancer: ASPREE

Lingering Gaps in CVD Care for Women Spotlighted in British Consensus Statement

Medicaid Coverage Improves CV Risk in Some, Post Hoc Analysis Shows

Debating a PCI-First Strategy in Stable CAD: ORBITA-2 vs the Unconvinced

MI Care Varies Across Asian Subgroups in the US

Little Pre- and Postmarket Testing for Most Recalled CV Devices

Tricuspid TEER Continues to Offer Benefits Through 3 Years: TRILUMINATE

Statins Are Cost-effective in the Elderly

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content